Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies-Reference-Cited by-同舟云学术

Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies

Published:2008-02 Issue:1 Volume:863 Page:19-25
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Patel Katan,Guichard Sylvie M.,Jodrell Duncan I.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference31 articles.

1. The Hallmarks of Cancer

2. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

3. Epigenomics and epigenetic therapy of cancer

4. CpG-island methylation and epigenetic control of resistance to chemotherapy

5. DNA Demethylating Agents and Chromatin-Remodelling Drugs: Which, How and Why?

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS/MS method for murine plasma analysis;Journal of Chromatography B;2024-07

2. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-04

3. Exploiting second-order advantage for simultaneous biosensing of romidepsin and vorinostat in the presence of belinostat as uncalibrated interference in human serum samples;International Journal of Electrochemical Science;2024-01

4. Pharmacokinetic Assessment of Low Dose Decitabine in Combination Therapies: Development and Validation of a Sensitive Uhplc-Ms/Ms Method for Murine Plasma Analysis;2024

5. A critical assessment on stability behaviour of Vorinostat using LC-MS-QTOF with H/D exchange and NMR;Journal of Pharmaceutical and Biomedical Analysis;2023-11